Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Debt / NOTE 1.500% 3/1
-
Market price (% of par)
-
149.07%
-
Total 13F principal
-
$558,481,664
-
Principal change
-
+$2,278,000
-
Total reported market value
-
$832,818,971
-
Number of holders
-
61
-
Value change
-
+$3,407,537
-
Number of buys
-
1
-
Number of sells
-
1
Institutional Holders of SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 as of Q4 2013
As of 31 Dec 2013,
SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 was held by
61 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$558,481,664
in principal (par value) of the bond.
The largest 10 bondholders included
CALAMOS ADVISORS LLC, Invesco Ltd., PRUDENTIAL PLC, OAKTREE CAPITAL MANAGEMENT LP, ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Pioneer Investment Management Inc, BANK OF AMERICA CORP /DE/, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
61
institutional bondholders reporting positions
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.